106 studies found for:    new onset type 1 diabetes
Show Display Options
Rank Status Study
1 Recruiting New Onset Type 1 Diabetes: Role of Exenatide
Conditions: Type 1 Diabetes;   New Onset Type 1 Diabetes
Interventions: Drug: Exenatide;   Drug: Rapid and long acting insulin;   Drug: long acting insulin + rapid acting + 1.25 mcg Exenatide
2 Terminated
Has Results
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Drug: Antithymocyte globulin;   Drug: Placebo
3 Recruiting Phase II-III Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Condition: New Onset Type-1 Diabetes
Interventions: Biological: Alpha-1 Antitrypsin;   Other: Placebo
4 Completed Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: Placebo control
5 Completed Inducing Remission in Type 1 Diabetes With Alefacept
Condition: New-onset Type 1 Diabetes Mellitus
Interventions: Biological: Alefacept;   Drug: Placebo
6 Completed Trial of Otelixizumab for Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-1
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: otelixizumab infusion plus physician determined standard of care;   Biological: placebo infusion plus physician determined standard of care
7 Completed A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: NBI-6024
8 Recruiting Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: 180 mg/kg Alpha1-PI;   Biological: 90 mg/kg Alpha1-PI;   Biological: Placebo
9 Recruiting Efficacy and Safety Study of Autologous Hematopoietic Stem Cell Transplantation to Treat New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Intervention: Procedure: immunosuppression and stem cell transplantation
10 Terminated
Has Results
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
Conditions: Diabetes Mellitus Type 1;   Autoimmune Diabetes
Interventions: Drug: Insulin;   Drug: Lansoprazole;   Drug: Sitagliptin;   Biological: Diamyd;   Drug: GAD65 (Diamyd)
11 Not yet recruiting ATG-GCSF in New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Anti-Thymocyte Globulin (ATG)/Placebo;   Drug: Granulocyte colony stimulating factor (GCSF)
12 Completed Use of a Telehomecare Program for Young Patients With New Onset Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Device: Telehomecare (Intelligent Distance Patient Monitoring);   Other: Standard education and follow up at diabetes clinic
13 Withdrawn Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: efalizumab;   Drug: placebo
14 Completed Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: 1,25-dihydroxy-vitamin D3 (calcitriol);   Drug: placebo
15 Recruiting Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
Conditions: Type 1 Diabetes;   Insulin Dependent Diabetes;   Juvenile Onset Diabetes Mellitus;   Autoimmune Diabetes
Intervention: Drug: Vildagliptin
16 Completed Trial of Otelixizumab for Adolescents and Adults With Newly Diagnosed Type 1 Diabetes Mellitus (Autoimmune): DEFEND-2
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: Otelixizumab;   Biological: Placebo
17 Completed Anti-Interleukin-1 in Diabetes Action
Condition: Type 1 Diabetes
Interventions: Drug: anakinra;   Drug: saline
18 Completed Etanercept in New Onset Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Etanercept;   Drug: Placebo
19 Unknown  New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Mycophenolate mofeteil (MMF);   Drug: Daclizumab (DZB)
20 Not yet recruiting Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
Condition: Type 1 Diabetes
Intervention: Drug: Ustekinumab

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years